Current status and research progress in drug therapy for castration-resistant prostate cancer
10.3969/j.issn.1000-8179.2020.08.335
- VernacularTitle: 去势抵抗性前列腺癌药物治疗现状与进展
- Author:
Kaopeng GUAN
1
Author Information
1. Department of Urology, National Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- Publication Type:Journal Article
- Keywords:
Castration-resistant prostate cancer (CRPC);
Drug therapy;
Progress
- From:
Chinese Journal of Clinical Oncology
2020;47(8):384-387
- CountryChina
- Language:Chinese
-
Abstract:
The incidence and mortality of prostate cancer have steadily increased. As such, the prevention and treatment of prostate cancer are important. Standardized drug therapy in patients with castration-resistant prostate cancer (CRPC) is crucial for improving survival and quality of life. Here, we review the current situation and latest research progress in drug therapy for CRPC.
